CLOs on the Move

Neptune Corporation

www.neptunecorp.com

 
Neptune Wellness is a publicly-held modern, (plant forward) CPG company driven by a singular purpose: to transform the everyday for a healthier tomorrow. Building upon our 20+ years of expertise in nutraceutical manufacturing and cannabis extraction, as well as a superior seed to shelf supply chain, we`re developing a suite of good-for-you, good-for-the-planet consumer brands across multiple verticals – including nutraceuticals, cannabis, personal care & beauty, food & beverage, and home. This transition to a fully integrated consumer packaged goods company enables Neptune to forge a new path in consumer health and wellness, with industry-changing implications.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.neptunecorp.com
  • 545 Promenade Du Centropolis Suite 100
    Laval, QC CAN H7T 0A3
  • Phone: 888.664.9166

Executives

Name Title Contact Details
John Wirt
General Counsel Profile

Similar Companies

First Care Ambulance

First Care Ambulance is a Aurora, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Hycor Biomedical Inc.

Hycor Biomedical Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Kao Brands

Kao Brands Company is a leading manufacturer of premium beauty care brands that are recognized around the world for their innovation and quality.

Slimsational Solutions

Slimsational Solutions is a Windham, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immune Pharmaceuticals

Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.